The honesty, integrity and sound judgment of Pressure BioSciences, Inc’s (“PBI” or “the Company”) senior financial officers, which includes PBI’s principal financial officer, principal accounting officer, controller and other persons performing similar functions (“the Senior Financial Officers”), is fundamental to the financial reporting process and the reputation and success of PBI. PBI’s President and CEO and Senior Financial Officers hold an important and elevated role in corporate governance in that they are uniquely capable and empowered to ensure that all stakeholders’ interest are appropriately balanced, protected and preserved. Because of this special role, the President and CEO and each of the Senior Financial Officers agree to be bound by this Code of Ethics for Senior Financial Officers and each agrees that he or she will:
Each of the Senior Financial Officers and the President and CEO are expected to adhere to this Code of Ethics for Senior Financial Officers and all other applicable Codes of Business Ethics and Conduct of PBI at all times. Any violations of either of these codes shall be reported in accordance with the procedures set forth in PBI’s Whistle Blower Policy. If any Senior Financial Officer or the President and CEO is found to be in violation of this Code of Ethics for Senior Financial Officers, such person will be subject to disciplinary action, including termination of employment. It is against PBI policy to retaliate against any employee for good faith reporting of this Code.
The Board of Directors (or, if permitted under the applicable SEC and Nasdaq Marketplace Rules, the Audit Committee of the Board of Directors) shall have the sole discretionary authority to approve any deviation or waiver from this Code of Ethics for Senior Financial Officers, or any waiver and grounds for such waiver for a Senior Financial Officer or the President and CEO must be publicly disclosed promptly in the manner specified by the SEC rules.